{"mainPropery":{"diseaseId":9671,"diseaseName":"Lipodermatosclerosis","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/9671/lipodermatosclerosis","synonyms":["Acute lipodermatosclerosis","Hypodermitis sclerodermaformis","Sclerosing panniculitis"],"synonyms-with-source":[{"name":"Acute lipodermatosclerosis"},{"name":"Hypodermitis sclerodermaformis"},{"name":"Sclerosing panniculitis"}],"identifiers":[{"identifierType":"UMLS","identifierId":"C0406500"}]},"diseaseCategories":[],"organizations":[],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed/?term=Lipodermatosclerosis%5BTitle%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Lipodermatosclerosis. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1550,"resourceId":2178,"resourceName":"DermNet New Zealand","descriptionText":"<a href='http://dermnetnz.org/vascular/lipodermatosclerosis.html' target='_blank'>DermNet NZ</a> is an online resource about skin diseases developed by the New Zealand Dermatological Society Incorporated. DermNet NZ provides information about this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/MESH:C537026' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2788,"resourceId":4331,"resourceName":"Herbst - Review article","descriptionText":"Herbst KL. <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK552156/\">Subcutaneous Adipose Tissue Diseases: Dercum Disease, Lipedema, Familial Multiple Lipomatosis, and Madelung Disease</a>. [Updated 2019 Dec 14]. In: Feingold KR, Anawalt B, Boyce A, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.","resourceClassificationName":"Overview","resourceClassificationSectionName":"Selected Full-Text Journal Articles"}],"overviewQuestion":{"questionId":247,"questionText":"What is lipodermatosclerosis?","answerText":"<strong>Lipodermatosclerosis</strong> refers to changes in the skin of the lower legs. It is a form of <a href=\"http://dermnetnz.org/dermal-infiltrative/panniculitis.html\" target=\"_blank\">panniculitis</a> (inflammation of the layer of fat under the skin). Signs and symptoms include pain, hardening of skin, change in skin color (redness), swelling, and a tapering of the legs above the ankles.[174][8052] The exact underlying cause is unknown; however, it appears to be associated with <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000203.htm\" target=\"_blank\">venous insufficiency</a> and/or obesity. Treatment usually includes <a href=\"http://www.dermnetnz.org/procedures/compression.html\" target=\"_blank\">compression therapy</a>.[8052]","dateModified":"2014-12-31T00:00:00"},"basicQuestions":[{"questionId":249,"questionText":"What are the signs and symptoms of&nbsp;lipodermatosclerosis?","answerText":"Lipodermatosclerosis refers to changes in the skin of the lower legs. One or both legs may be involved. Signs and symptoms vary but may include:[174][8052]\r\n<ul>\r\n    <li>Pain</li>\r\n    <li>Hardening and/or thickening of the skin</li>\r\n    <li><a href=\"http://www.nlm.nih.gov/medlineplus/varicoseveins.html\" target=\"_blank\">Varicose veins</a></li>\r\n    <li>Changes in skin color (redness)</li>\r\n    <li>Small white scarred areas (<a href=\"http://www.dermnetnz.org/vascular/atrophie-blanche.html\" target=\"_blank\">atrophie blanche</a>) </li>\r\n    <li>Swelling</li>\r\n    <li><a href=\"http://www.dermnetnz.org/site-age-specific/leg-ulcers.html\" target=\"_blank\">Leg ulcers</a> </li>\r\n    <li>Tapering of the legs above the ankles</li>\r\n</ul>","dateModified":"2014-12-31T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":174,"authors":"Bruce AJ. et al","articleTitle":"Lipodermatosclerosis: Review of cases evaluated at Mayo Clinic","bookWebsiteJournalTitle":"J Am Acad Dermatol","date":"2002"},{"referenceId":8052,"authors":"Mark Duffill","articleTitle":"Lipodermatosclerosis","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2013","volume":"","pages":"","url":"http://www.dermnetnz.org/vascular/lipodermatosclerosis.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":250,"questionText":"What causes lipodermatosclerosis?","answerText":"The exact cause of lipodermatosclerosis is unknown; however, it may be related to certain vein abnormalities and/or obesity. Lipodermatosclerosis often occurs in people with <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000203.htm\" target=\"_blank\">venous insufficiency</a>. Approximately two thirds of affected people are obese.[174][8052]","dateModified":"2014-12-31T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":174,"authors":"Bruce AJ. et al","articleTitle":"Lipodermatosclerosis: Review of cases evaluated at Mayo Clinic","bookWebsiteJournalTitle":"J Am Acad Dermatol","date":"2002"},{"referenceId":8052,"authors":"Mark Duffill","articleTitle":"Lipodermatosclerosis","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2013","volume":"","pages":"","url":"http://www.dermnetnz.org/vascular/lipodermatosclerosis.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":8086,"questionText":"How is lipodermatosclerosis diagnosed?","answerText":"Lipodermatosclerosis is usually diagnosed based on the presence of characteristic signs and symptoms. A <a href=\"http://www.dermnetnz.org/procedures/biopsy.html\" target=\"_blank\">skin biopsy</a> and/or blood tests are usually not required to confirm a diagnosis but may be performed in rare cases. <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003775.htm\" target=\"_blank\">Ultrasound scans</a> and/or <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/003335.htm\" target=\"_blank\">magnetic resonance imaging (MRI)</a> may be used to obtain more information regarding the severity of the condition and to determine the best treatment approach.[8052]","dateModified":"2014-12-31T13:50:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":8052,"authors":"Mark Duffill","articleTitle":"Lipodermatosclerosis","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2013","volume":"","pages":"","url":"http://www.dermnetnz.org/vascular/lipodermatosclerosis.html","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":252,"questionText":"How might lipodermatosclerosis be treated?","answerText":"Lipodermatosclerosis is primarily treated with <a href=\"http://www.dermnetnz.org/procedures/compression.html\" target=\"_blank\">compression therapy</a> to improve <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000203.htm\" target=\"_blank\">venous insufficiency</a>.[8052] Other strategies for managing venous insufficiency include leg elevation; not sitting or standing in one place for long periods of time; regular exercise; and weight loss if overweight or obese.[8053] Some affected people may require medications to prevent blood clotting; reduce pain and inflammation; and/or increase blood flow. Depending on the severity of the condition and the response to initial treatments, vein surgery may be recommended.[8052]","dateModified":"2014-12-31T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":8052,"authors":"Mark Duffill","articleTitle":"Lipodermatosclerosis","bookWebsiteJournalTitle":"DermNet NZ","date":"December 2013","volume":"","pages":"","url":"http://www.dermnetnz.org/vascular/lipodermatosclerosis.html","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":8053,"authors":"","articleTitle":"Venous Insufficiency","bookWebsiteJournalTitle":"MedlinePlus","date":"May 2014","volume":"","pages":"","url":"http://www.nlm.nih.gov/medlineplus/ency/article/000203.htm","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[],"medicalProducts":[],"EncodedName":"Lipodermatosclerosis"}